A new study may help doctors assess the long-term risk for major bleeding if anticoagulation for unprovoked venous thromboembolisms (VTE) is continued beyond 3-6 months. The meta-analysis of data from 27 studies with 17,202 patients was published in the Annals…
Read More
New ASH Guidelines: VTE Prevention, Treatment in Cancer Patients
New guidelines from the American Society of Hematology “strongly recommend” using no thromboprophylaxis over using parenteral thromboprophylaxis in ambulatory patients receiving cancer chemotherapy who have low venous thromboembolism (VTE) risk, and using no thromboprophylaxis over oral thromboprophylaxis with vitamin K…
Read More
Subarachnoid hemorrhage causes more deaths among middle-aged women than other strokes
Subarachnoid hemorrhage (SAH), the most fatal of all cerebrovascular disturbances, results in death for 40-50% of patients suffering from the condition in the first months after the hemorrhage. The annual incidence of SAH is considered to be six to seven…
Read More
Study reveals risk factors for acute kidney injury after brain hemorrhage
Patients who suffer an intracerebral hemorrhage (ICH) face an increased risk of acute kidney injury (AKI) during their hospitalization. AKI can lead to sudden kidney failure, kidney damage or even death. Researchers from the University of Missouri School of Medicine…
Read More